The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?

The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology letters 2010-01, Vol.1 (1), p.187-188
Hauptverfasser: LIM, S.Y, HORSMAN, J.M, HANCOCK, B.W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 188
container_issue 1
container_start_page 187
container_title Oncology letters
container_volume 1
creator LIM, S.Y
HORSMAN, J.M
HANCOCK, B.W
description The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.
doi_str_mv 10.3892/ol_00000034
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3436357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859678169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhi1UBBFw4l75hCqhBX9sbG8Praq0QKSg9pBeuFjOejZx2bUX26Hl37M0EGA00oz0PnpnNIPQMSVnXFXsPLSa_A9e7qARlRUrKFHsw7aX5T46SunPEzMWVCmxh_YZq4RgiozQzXwF-Nr43AKeQNvi2UPXr0Jn8NRniN5kF7xp8a8Ylj6k7OpBsPDvM_4eIGGX8d8Qb7HzOIZ1dh5wH009YPD1EO02pk1w9FwP0O-LH_PJVTH7eTmdfJsVdUlZLpiUfNFw0gA0isoSFGdWCsoIY9aKUjGlDC8Nrw0MirUSFlAzIgiMmRKMH6AvG99-vejA1uBzNK3uo-tMfNDBOP1e8W6ll-Fe85ILPpaDwadngxju1pCy7lyqh2MYD2GdNFXjSkhFRTWgpxu0jiGlCM12DCX66SH6zUMG-uPbzbbsy_kH4GQDpN5462xIr2u3BaGbVJI_Ajl2k10</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859678169</pqid></control><display><type>article</type><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><source>Spandidos Publications Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</creator><creatorcontrib>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</creatorcontrib><description>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol_00000034</identifier><identifier>PMID: 22966280</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Mantle Cell Lymphoma International Prognostic Index</subject><ispartof>Oncology letters, 2010-01, Vol.1 (1), p.187-188</ispartof><rights>Copyright © 2010, Spandidos Publications</rights><rights>Copyright © 2010, Spandidos Publications 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</citedby><cites>FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436357/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436357/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,5556,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22966280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIM, S.Y</creatorcontrib><creatorcontrib>HORSMAN, J.M</creatorcontrib><creatorcontrib>HANCOCK, B.W</creatorcontrib><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><title>Oncology letters</title><addtitle>Oncol Lett</addtitle><description>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</description><subject>Mantle Cell Lymphoma International Prognostic Index</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpVkU1PGzEQhi1UBBFw4l75hCqhBX9sbG8Praq0QKSg9pBeuFjOejZx2bUX26Hl37M0EGA00oz0PnpnNIPQMSVnXFXsPLSa_A9e7qARlRUrKFHsw7aX5T46SunPEzMWVCmxh_YZq4RgiozQzXwF-Nr43AKeQNvi2UPXr0Jn8NRniN5kF7xp8a8Ylj6k7OpBsPDvM_4eIGGX8d8Qb7HzOIZ1dh5wH009YPD1EO02pk1w9FwP0O-LH_PJVTH7eTmdfJsVdUlZLpiUfNFw0gA0isoSFGdWCsoIY9aKUjGlDC8Nrw0MirUSFlAzIgiMmRKMH6AvG99-vejA1uBzNK3uo-tMfNDBOP1e8W6ll-Fe85ILPpaDwadngxju1pCy7lyqh2MYD2GdNFXjSkhFRTWgpxu0jiGlCM12DCX66SH6zUMG-uPbzbbsy_kH4GQDpN5462xIr2u3BaGbVJI_Ajl2k10</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>LIM, S.Y</creator><creator>HORSMAN, J.M</creator><creator>HANCOCK, B.W</creator><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201001</creationdate><title>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</title><author>LIM, S.Y ; HORSMAN, J.M ; HANCOCK, B.W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-2773bf30feef8174e832d7612022dd648288a34a3cae32ddd7ebec2060e528623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Mantle Cell Lymphoma International Prognostic Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LIM, S.Y</creatorcontrib><creatorcontrib>HORSMAN, J.M</creatorcontrib><creatorcontrib>HANCOCK, B.W</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIM, S.Y</au><au>HORSMAN, J.M</au><au>HANCOCK, B.W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?</atitle><jtitle>Oncology letters</jtitle><addtitle>Oncol Lett</addtitle><date>2010-01</date><risdate>2010</risdate><volume>1</volume><issue>1</issue><spage>187</spage><epage>188</epage><pages>187-188</pages><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in advanced mantle cell lymphoma using data from patients treated in clinical trials. To evaluate its use in routine practice, we applied the simplified index retrospectively to 50 consecutive new patients attending our lymphoma service. In the log-rank and multiple comparison statistical tests there was favorable differentiation between survival curves, and particularly between the high- and low-risk groups. We concluded that the MIPI is of value in routine lymphoma practice.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>22966280</pmid><doi>10.3892/ol_00000034</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Oncology letters, 2010-01, Vol.1 (1), p.187-188
issn 1792-1074
1792-1082
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3436357
source Spandidos Publications Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Mantle Cell Lymphoma International Prognostic Index
title The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A18%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Mantle%20Cell%20Lymphoma%20International%20Prognostic%20Index:%20Does%20it%20work%20in%20routine%20practice?&rft.jtitle=Oncology%20letters&rft.au=LIM,%20S.Y&rft.date=2010-01&rft.volume=1&rft.issue=1&rft.spage=187&rft.epage=188&rft.pages=187-188&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol_00000034&rft_dat=%3Cproquest_pubme%3E1859678169%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1859678169&rft_id=info:pmid/22966280&rfr_iscdi=true